Format

Send to

Choose Destination
Eur J Neurosci. 2013 Oct;38(7):2973-7. doi: 10.1111/ejn.12307. Epub 2013 Jul 21.

Challenges of proper placebo control for non-invasive brain stimulation in clinical and experimental applications.

Author information

1
School of Psychology, Bangor University, Bangor LL57 2AS, UK. n.davis@bangor.ac.uk
2
Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Boston, MA, USA.
3
School of Psychology, Bangor University, Bangor, LL57 2AS, UK.
4
School of Medical Sciences, Bangor University, Bangor, UK.
5
Walton Centre for Neurology and Neurosurgery, Liverpool, UK.

Abstract

A range of techniques are now available for modulating the activity of the brain in healthy people and people with neurological conditions. These techniques, including transcranial magnetic stimulation (TMS) and transcranial current stimulation (tCS, which includes direct and alternating current), create magnetic or electrical fields that cross the intact skull and affect neural processing in brain areas near to the scalp location where the stimulation is delivered. TMS and tCS have proved to be valuable tools in behavioural neuroscience laboratories, where causal involvement of specific brain areas in specific tasks can be shown. In clinical neuroscience, the techniques offer the promise of correcting abnormal activity, such as when a stroke leaves a brain area underactive. As the use of brain stimulation becomes more commonplace in laboratories and clinics, we discuss the safety and ethical issues inherent in using the techniques with human participants, and we suggest how to balance scientific integrity with the safety of the participant.

KEYWORDS:

brain stimulation; ethics; transcranial alternating current stimulation; transcranial direct current stimulation; transcranial magnetic stimulation

PMID:
23869660
DOI:
10.1111/ejn.12307
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center